Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 40
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101411-101411
Open Access | Times Cited: 10
Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Alternative splicing in prostate cancer progression and therapeutic resistance
Chitra Rawat, Hannelore V. Heemers
Oncogene (2024) Vol. 43, Iss. 22, pp. 1655-1668
Open Access | Times Cited: 8
Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research
Weijing Wang, Yongshu Li, Kaida Lin, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 5, pp. 381-398
Open Access | Times Cited: 14
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours
Julia Simon, Luis Gustavo Perez‐Rivas, Yining Zhao, et al.
European Journal of Endocrinology (2023) Vol. 189, Iss. 3, pp. 372-378
Closed Access | Times Cited: 13
Somatic Mutations in Core Spliceosome Components Promote Tumorigenesis and Generate an Exploitable Vulnerability in Human Cancer
Claudio Sette, Maria Paola Paronetto
Cancers (2022) Vol. 14, Iss. 7, pp. 1827-1827
Open Access | Times Cited: 21
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
Juan L López-Cánovas, Natalia Hermán‐Sánchez, María Trinidad Moreno-Montilla, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 19
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors
Sergio Pedraza‐Arévalo, Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, et al.
Translational research (2022) Vol. 251, pp. 63-73
Closed Access | Times Cited: 16
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets
Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, María Trinidad Moreno‐Montilla, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 3
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
Emilia Alors‐Pérez, Sergio Pedraza‐Arévalo, Ricardo Blázquez‐Encinas, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain
Oarteze Hunter, Jason Talkish, Jen Quick-Cleveland, et al.
RNA (2023) Vol. 30, Iss. 2, pp. 149-170
Open Access | Times Cited: 7
Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery
Ricardo Blázquez‐Encinas, Víctor García‐Vioque, Teresa Caro-Cuenca, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target
Rocco Sciarrillo, Francesca Terrana, Annalisa Comandatore, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 3173-3184
Open Access | Times Cited: 2
Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features
Alba Sanjuan‐Sanjuan, Emilia Alors‐Pérez, Marina Sánchez‐Frías, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6929-6929
Open Access | Times Cited: 2
Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer
Chiara Naro, Veronica Ruta, Claudio Sette
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 2
Dysregulation of splicing variants and spliceosome components in breast cancer
Manuel D. Gahete, Natalia Hermán‐Sánchez, Antonio C. Fuentes-Fayos, et al.
Endocrine Related Cancer (2022) Vol. 29, Iss. 9, pp. R123-R142
Open Access | Times Cited: 12
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer
Patrik Simmler, Cédric Cortijo, Lisa Maria Koch, et al.
Cell Reports (2022) Vol. 40, Iss. 8, pp. 111266-111266
Open Access | Times Cited: 8
One Host-Multiple Applications: Zebrafish (Danio rerio) as Promising Model for Studying Human Cancers and Pathogenic Diseases
Karolina Dudziak, Michał Nowak, Magdalena Sozoniuk
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10255-10255
Open Access | Times Cited: 8
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response
Emilia Alors‐Pérez, Sergio Pedraza‐Arévalo, Ricardo Blázquez‐Encinas, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 35, Iss. 1, pp. 102090-102090
Open Access | Times Cited: 4
Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment
Antonio J. Montero‐Hidalgo, Jesús M. Pérez‐Gómez, Antonio J. Martínez‐Fuentes, et al.
Wiley Interdisciplinary Reviews - RNA (2022) Vol. 14, Iss. 3
Open Access | Times Cited: 7
How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
Weronika Wojtyś, Magdalena Oroń
Cancers (2023) Vol. 15, Iss. 11, pp. 2918-2918
Open Access | Times Cited: 3
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma
Ricardo Blázquez‐Encinas, Emilia Alors‐Pérez, María Trinidad Moreno-Montilla, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1646-1657
Open Access
The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer
Natalia Hermán‐Sánchez, Miguel E. G-García, Juan M. Jiménez-Vacas, et al.
Cellular and Molecular Life Sciences (2024) Vol. 82, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top